Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Definitive Healthcare Corp (DH – Research Report), Orthofix (OFIX – Research Report) and Pharming Group (PHGUF – Research Report).
Definitive Healthcare Corp (DH)
In a report released today, Craig Hettenbach from Morgan Stanley downgraded Definitive Healthcare Corp to Hold, with a price target of $9.00. The company’s shares closed last Tuesday at $7.25.
According to TipRanks.com, Hettenbach is ranked #850 out of 8824 analysts.
Currently, the analyst consensus on Definitive Healthcare Corp is a Hold with an average price target of $10.00.
See today’s best-performing stocks on TipRanks >>
Orthofix (OFIX)
Orthofix received a Buy rating and a $20.00 price target from Roth MKM analyst Jason Wittes today. The company’s shares closed last Tuesday at $13.89.
According to TipRanks.com, Wittes is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Orthofix with a $17.00 average price target.
Pharming Group (PHGUF)
Stifel Nicolaus analyst Christian Glennie maintained a Buy rating on Pharming Group today and set a price target of EUR2.05. The company’s shares closed last Friday at $0.95, close to its 52-week low of $0.91.
According to TipRanks.com, Glennie is ranked #8359 out of 8824 analysts.
Pharming Group has an analyst consensus of Moderate Buy, with a price target consensus of $2.09.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DH:
- Definitive Healthcare launches Carevoyance sales enablement solution
- VML and Definitive Healthcare announce partnership to transform key opinion leader management
- Definitive Healthcare management to meet virtually with Needham
- Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal
